Literature DB >> 23182396

The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.

Kenneth B Roberts1, Pamela R Soulos, Jeph Herrin, James B Yu, Jessica B Long, Edward Dostaler, Cary P Gross.   

Abstract

PURPOSE: New radiation therapy modalities have broadened treatment options for older women with breast cancer, but it is unclear how clinical factors, geographic region, and physician preference affect the choice of radiation therapy modality. METHODS AND MATERIALS: We used the Surveillance, Epidemiology, and End Results-Medicare database to identify women diagnosed with stage I-III breast cancer from 1998 to 2007 who underwent breast-conserving surgery. We assessed the temporal trends in, and costs of, the adoption of intensity modulated radiation therapy (IMRT) and brachytherapy. Using hierarchical logistic regression, we evaluated the relationship between the use of these new modalities and patient and regional characteristics.
RESULTS: Of 35,060 patients, 69.9% received conventional external beam radiation therapy (EBRT). Although overall radiation therapy use remained constant, the use of IMRT increased from 0.0% to 12.6% from 1998 to 2007, and brachytherapy increased from 0.7% to 9.0%. The statistical variation in brachytherapy use attributable to the radiation oncologist and geographic region was 41.4% and 9.5%, respectively (for IMRT: 23.8% and 22.1%, respectively). Women undergoing treatment at a free-standing radiation facility were significantly more likely to receive IMRT than were women treated at a hospital-based facility (odds ratio for IMRT vs EBRT: 3.89 [95% confidence interval, 2.78-5.45]). No such association was seen for brachytherapy. The median radiation therapy cost per treated patient increased from $5389 in 2001 to $8539 in 2007.
CONCLUSIONS: IMRT and brachytherapy use increased substantially from 1998 to 2007; overall, radiation therapy costs increased by more than 50%. Radiation oncologists played an important role in treatment choice for both types of radiation therapy, whereas geographic region played a bigger role in the use of IMRT than brachytherapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23182396      PMCID: PMC3606652          DOI: 10.1016/j.ijrobp.2012.10.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

Review 2.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Development of a comorbidity index using physician claims data.

Authors:  C N Klabunde; A L Potosky; J M Legler; J L Warren
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

6.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

Authors:  Jean-Philippe Pignol; Ivo Olivotto; Eileen Rakovitch; Sandra Gardner; Katharina Sixel; Wayne Beckham; Thi Trinh Thuc Vu; Pauline Truong; Ida Ackerman; Lawrence Paszat
Journal:  J Clin Oncol       Date:  2008-02-19       Impact factor: 44.544

7.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.

Authors:  Kevin S Hughes; Lauren A Schnaper; Donald Berry; Constance Cirrincione; Beryl McCormick; Brenda Shank; Judith Wheeler; Lorraine A Champion; Thomas J Smith; Barbara L Smith; Charles Shapiro; Hyman B Muss; Eric Winer; Clifford Hudis; William Wood; David Sugarbaker; I Craig Henderson; Larry Norton
Journal:  N Engl J Med       Date:  2004-09-02       Impact factor: 91.245

8.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Authors:  Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

10.  Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.

Authors:  Grace L Smith; Ying Xu; Ya-Chen T Shih; Sharon H Giordano; Benjamin D Smith; Kelly K Hunt; Eric A Strom; George H Perkins; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Am Coll Surg       Date:  2009-08-20       Impact factor: 6.113

View more
  22 in total

1.  Physician's peer exposure and the adoption of a new cancer treatment modality.

Authors:  Craig Evan Pollack; Pamela R Soulos; Cary P Gross
Journal:  Cancer       Date:  2015-04-22       Impact factor: 6.860

2.  The impact of radiotherapy costs on clinical outcomes in breast cancer.

Authors:  Isabel J Boero; Anthony J Paravati; Daniel P Triplett; Lindsay Hwang; Rayna K Matsuno; Loren K Mell; James D Murphy
Journal:  Radiother Oncol       Date:  2015-10-20       Impact factor: 6.280

3.  Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Authors:  Shervin M Shirvani; Jing Jiang; Daniel R Gomez; Joe Y Chang; Thomas A Buchholz; Benjamin D Smith
Journal:  Lung Cancer       Date:  2013-08-21       Impact factor: 5.705

4.  Association between hospital case volume and the use of bronchoscopy and esophagoscopy during head and neck cancer diagnostic evaluation.

Authors:  Gordon H Sun; Oluseyi Aliu; Nicholas M Moloci; Joshua K Mondschein; James F Burke; Rodney A Hayward
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.860

5.  Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.

Authors:  Sounok Sen; Shi-Yi Wang; Pamela R Soulos; Kevin D Frick; Jessica B Long; Kenneth B Roberts; James B Yu; Suzanne B Evans; Anees B Chagpar; Cary P Gross
Journal:  J Natl Cancer Inst       Date:  2014-03-05       Impact factor: 13.506

6.  Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality.

Authors:  Shi-Yi Wang; Jessica B Long; Brigid K Killelea; Suzanne B Evans; Kenneth B Roberts; Andrea L Silber; Amy J Davidoff; Tannaz Sedghi; Cary P Gross
Journal:  Breast Cancer Res Treat       Date:  2018-08-11       Impact factor: 4.872

7.  Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life.

Authors:  Rong Wang; Amer M Zeidan; Stephanie Halene; Xiao Xu; Amy J Davidoff; Scott F Huntington; Nikolai A Podoltsev; Cary P Gross; Steven D Gore; Xiaomei Ma
Journal:  J Clin Oncol       Date:  2017-08-07       Impact factor: 44.544

8.  Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors.

Authors:  Ying Liu; Derek T Schloemann; Min Lian; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2015-04-19       Impact factor: 4.872

9.  What drives variation in spending for breast cancer patients within geographic regions?

Authors:  Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum
Journal:  Health Serv Res       Date:  2018-10-14       Impact factor: 3.402

10.  Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.

Authors:  Ami Vyas; S Suresh Madhavan; Usha Sambamoorthi; Xiaoyun Lucy Pan; Michael Regier; Hannah Hazard; Sita Kalidindi
Journal:  J Natl Compr Canc Netw       Date:  2017-11       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.